In this research Sorbitol dehydrogenase (SDH) was partially purified from sera of patients with type I diabetes mellitus by dialysis and ion exchange chromatography step by step. One peak of SDH activity was obtained with specific activity of 40.065 unit/mg protein and with purification fold of 98.9 compared to crud enzyme. Inhibition of SDH
Introduction
Diabetes mellitus is a heterogeneous metabolic disorder characterized hyperglycemia resulting from defective insulin secretion, resistance to insulin action or both(1). Type I diabetes mellitus is the consequence of an autoimmune-toward pancreatic-β-cells leading to insulin deficiency (2) .
The major metabolic changes caused by hyperglycemia are increased glucose influx into the polyol pathway, elevated formation of oxygen-free radicals (3) . The polyol pathway synthesizes fructose from glucose in a series of passages. In the first of these, the enzyme aldos reductase reduced glucose to sugar alchohol sorbitol using NADPH as a cofactor (4), the increased glucose concentration is associated with the increase of polyol pathway activity (5) .
Sorbitol dehydrogenase (SDH) E.C(1.1.1.14) is a member of the superfamily of medium-chain dehydrogenases/reductases. SDH, the second enzyme in the polyol pathway, oxidizes sorbitol to fructose in the presence of NAD + and the enzyme SDH is considered an important part in this pathway. As a member of the alchohol dehydrogenase super family (6, 7) . High levels of SDH activity lead to increasing fructose availability (8) which plays an important role in the pathogenesis of diabetic complications (6) .
Recent studies show that SDH activity was increased during chronic ischemia and diabetes. Inhibition of SDH which plays an important role in reducing ischemic was associated with lower cytosolic NADH/NAD + and with increased glucose uptake and oxidation (7) .
At least increasing action of this pathway lead to many metabolism complication such as depletion of NADPH that it is very necessary to regeneration of antioxidant reduced glutathione (4), retinopathy (8) , effect of the nervous system and especially brain cells and increase oxidative stress (10) .
The aim of this study is inhibition of SDH activity (by Glibenclamide and Rosiglitazone drugs) which plays an important role in polyol pathway.
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Materials and Methods
Collection of samples: Venous blood samples were drawn from Patients with diabetes mellitus type I from Ibn-sina hospital -Mosul city-and by arrange (2-3) milliliter to one sample.
Blood serum isolation:-The serum is isolated by putting tubes in a water bath(37)°C for (10)min, and centrifuged at 1008xg for (10)min, the supernatant was taken to conserve in freezing (11) .
Determination of protein:
Biuret method was used to determine total protein concentration (12) .
Sorbitol dehydrogenase assay:-Sorbitol dehydrogenase (SDH) was assayed by method of Ulrich (13) . Increasing absorbance was measured spectrophotometrically by monitoring intervals for (5) We obtained one peak of SDH activity showing in Figure( 
Results and discussion
Inhibition of SDH activity:
SDH activity was inhibited by Glibenclamide and Rosiglitazone drugs with concentrations (1-10)mM . Table (2) show the concentration of both drugs that exhibited maximal inhibitory effect was (6)mM, and the percentage inhibition was (97.9%) 
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Glibenclamide also known as a glyburid (USAN), is an antidiabetic drug in a class of medication known as sulfonylurea, widely used to treatment patient with type II diabetes (15) . Thiazlidinediones are a new oral anti diabetic drugs that directly target insulin resistance (16) , Rosiglitazon is one of this family which is used to treat adult-onset type II diabetes (17) .
Polyol pathway is an important role in pathogenesis of diabetic neuropathy by dependant of biochemical pathways (18) , and the development of diabetes complications (19) . The SDH enzyme is one of this pathways member (7) , SDH activity was significantly increased in patients with type I diabetes (10) .
In this study we observed that some drugs which is given to the patients with diabetes type II can be inhibiting SDH. Lineweaver-Burk plot was noncompetitive inhibition by using Glibenclamide and Rosiglitazone drugs, Vmax without inhibitor was (22.175)unit/ml, whereas Vmax was (13.634), (14.615)unit/ml with both inhibitors respectively, figure (2) and (3). ٦ Km value is invariable (100)mM. The inhibition constants (Ki) value was (7) mM for both inhibitor.
Inhibition of SDH can be reduced metabolic abnormalities (20) , some studies indicated that SDH was inhibition by sorbitol competitive 1-thiosorbitol (21) , and several inhibitors provide competitive inactivation by DL-2-bromo-3-(5-imidazolyl) propionic acid (22) .
Finally, we obtained that the two inhibitors have a similar inhibiting properties on SDH activity. Whereas these inhibitors have the same structure which contains terminal active oxygen and sulfur atoms.
Inhibitory effect of aliphatic thiols (L-theritol and DL-1-phenyl-2ethandiol) and aromatic (1-thio-1-phenylmethane and 1-thio-2phenylethane) that responsible of interaction with an enzymatic hydrophobic site is important for inhibitor binding (21) , and this thiole are generally the most strong inhibitor of enzyme (22) . In this study the two inhibitor contain sulfur atom in its structure, there; may these atoms react with hydrophobic active site on SDH. 
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